These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7361675)

  • 1. Strength-interval relation in the human ventricle: effect of procainamide.
    Camardo JS; Greenspan AM; Horowitz LN; Spielman SR; Josephson ME
    Am J Cardiol; 1980 Apr; 45(4):856-60. PubMed ID: 7361675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between repolarization and refractoriness in the human ventricle: cycle length dependence and effect of procainamide.
    Lee RJ; Liem LB; Cohen TJ; Franz MR
    J Am Coll Cardiol; 1992 Mar; 19(3):614-8. PubMed ID: 1538018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strength-interval relation for ventricular functional refractoriness.
    Liem LB; Mason DM; Swerdlow CD
    Am J Cardiol; 1988 Jan; 61(1):88-92. PubMed ID: 3337023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of procainamide and lidocaine on total electrical systole of ventricular premature depolarizations.
    Giardina EG; Bigger JT
    Am J Med; 1975 Sep; 59(3):405-10. PubMed ID: 1163548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in ventricular refractoriness after an extrastimulus: effects of prematurity, cycle length and procainamide.
    Cain ME; Martin TC; Marchlinski FE; Josephson ME
    Am J Cardiol; 1983 Nov; 52(8):996-1001. PubMed ID: 6637852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of infarction, procainamide, coupling interval, and cycle length on refractoriness of extrastimuli.
    Marchlinski FE; Cain ME; Falcone RA; Corky RF; Spear JF; Josephson ME
    Am J Physiol; 1985 May; 248(5 Pt 2):H606-13. PubMed ID: 3993800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
    Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T
    Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human atrial strength-interval relation. Influence of cycle length and procainamide.
    Buxton AE; Marchlinski FE; Miller JM; Morrison DF; Frame LH; Josephson ME
    Circulation; 1989 Feb; 79(2):271-80. PubMed ID: 2914346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of lignocaine, procainamide, metoprolol, digoxin and atropine on human myocardial refractoriness.
    Edvardsson N; Hirsch I; Olsson SB
    Cardiovasc Res; 1984 Aug; 18(8):463-70. PubMed ID: 6467263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylprocainamide induced changes in refractoriness and monophasic action potentials of the dog heart in situ.
    Amlie JP; Landmark K
    Cardiovasc Res; 1981 Mar; 15(3):159-63. PubMed ID: 6167356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide.
    Windle J; Prystowsky EN; Miles WM; Heger JJ
    Clin Pharmacol Ther; 1987 Jun; 41(6):603-10. PubMed ID: 3581646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of procainamide on dispersion of ventricular refractoriness.
    Shechter JA; Caine R; Friehling T; Kowey PR; Engel TR
    Am J Cardiol; 1983 Aug; 52(3):279-82. PubMed ID: 6869273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate quantitation of antiarrhythmic drug effect by monophasic action potential recording in coronary artery disease.
    Platia EV; Weisfeldt ML; Franz MR
    Am J Cardiol; 1988 Jun; 61(15):1284-7. PubMed ID: 3376887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human ventricular refractoriness. II. Effects of procainamide.
    Kastor JA; Josephson ME; Guss SB; Horowitz LN
    Circulation; 1977 Sep; 56(3):462-7. PubMed ID: 884802
    [No Abstract]   [Full Text] [Related]  

  • 15. Procainamide administration during electrophysiology study--utility as a provocative test for intermittent atrioventricular block.
    Twidale N; Heddle WF; Tonkin AM
    Pacing Clin Electrophysiol; 1988 Oct; 11(10):1388-97. PubMed ID: 2462213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic effects of procainamide in subtherapeutic to therapeutic doses on human atrioventricular conduction system.
    Ogunkelu JB; Damato AN; Akhtar M; Reddy CP; Caracta AR; Lau SH
    Am J Cardiol; 1976 Apr; 37(5):724-31. PubMed ID: 773160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The electrophysiologic effects of procainamide in the immature heart.
    Shih JY; Gillette PC; Kugler JD; Garson A; Fukushige J; Zinner A; Driscoll DJ
    Pediatr Pharmacol (New York); 1982; 2(1):65-73. PubMed ID: 7110758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
    Derakhchan K; Pagé P; Lambert C; Kus T
    J Pharmacol Exp Ther; 1994 Jul; 270(1):47-54. PubMed ID: 8035342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic effects of N-acetylprocainamide in human beings.
    Jaillon P; Rubenson D; Peters F; Mason JW; Winkle RA
    Am J Cardiol; 1981 May; 47(5):1134-40. PubMed ID: 6164285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of procainamide on induced ventricular tachycardia.
    Engel TR; del Gonzalez A; Meister SG; Franki WS
    Clin Pharmacol Ther; 1978 Sep; 24(3):274-82. PubMed ID: 688720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.